Cargando…
Neurokinin-1 receptor drives PKCɑ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancer
The widespread application of antiandrogen therapies has aroused a significant increase in the incidence of NEPC, a lethal form of the disease lacking efficient clinical treatments. Here we identified a cell surface receptor neurokinin-1 (NK1R) as a clinically relevant driver of treatment-related NE...
Autores principales: | Zhang, Xiao-Wei, Li, Jing-Yi, Li, Lin, Hu, Wen-Qian, Tao, Yan, Gao, Wen-Yan, Ye, Zi-Nuo, Jia, Hao-Yuan, Wang, Jia-Nan, Miao, Xiao-Kang, Yang, Wen-Le, Wang, Rui, Mou, Ling-Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310825/ https://www.ncbi.nlm.nih.gov/pubmed/37385990 http://dx.doi.org/10.1038/s41419-023-05894-x |
Ejemplares similares
-
Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer
por: Ton, Anh-Tien, et al.
Publicado: (2020) -
Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR
por: Zhang, Xiao-Wei, et al.
Publicado: (2022) -
OTHR-02. CHIMERIC AURORA A KINASE (AURKA) DEGRADERS EFFICIENTLY TARGET N-MYC
por: Valinciute, Gintvile, et al.
Publicado: (2023) -
Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells
por: Yang, Yan, et al.
Publicado: (2020) -
Inhibition of AURKA kinase activity suppresses collective invasion in a microfluidic cell culture platform
por: Xia, Jiang-Long, et al.
Publicado: (2017)